Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

CRM and software-as-a-service

December 21, 2010 Sales and Marketing CRM, Dan Goldsmith, Service Insight, Veeva Systems

Service Insight from Dan Goldsmith, general manager, Europe, Veeva SystemsCriminal mastermind, Frank Abagnale Jr. (1901-1980), successfully conned millions of dollars …
Feature

FDA delays approval of AstraZeneca’s Brilinta

December 20, 2010 Research and Development, Sales and Marketing AZ, AstraZeneca, Brilinta, Brilique, acute coronary syndrome

US regulators have delayed approving AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor) because their want more information about a crucial clinical trial. …
News

Pharma careers options – management in China

December 17, 2010 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment

Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …
Feature

New hepatitis C drug offers cure for more patients

December 17, 2010 Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir

A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …
News

Government consults on UK value-based pricing

December 17, 2010 Sales and Marketing ABPI, Drug pricing, pharma pricing, value-based pricing

The government has begun a consolutation process for its plans to change the way medicines are priced in the UK. …
News

Merck KGaA appoints new head of pharma

December 17, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
Appointment

Race on to find new Johnson & Johnson leader

December 16, 2010 Sales and Marketing Johnson & Johnson, recruitment

Johnson & Johnson is promoting two of its most senior executives as it prepares to replace William Weldon, its current …
News

Novartis becomes global eye health leader as Alcon deal finalised

December 15, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology

Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
News

GSK buys sports nutrition company for £162m

December 14, 2010 Sales and Marketing GSK, GlaxoSmithKline, Maximuscle, Maxinutrition, consumer healthcare, sports nutrition

GlaxoSmithKline has acquired UK sports nutrition firm Maxinutrition for £162 million to help broaden its consumer portfolio. The company already …
News

Pfizer withdraws hypertension drug Thelin

December 14, 2010 Sales and Marketing PAH, Pfizer, Thelin, liver damage, liver toxicity, patient safety, pulmonary arterial hypertension, sitaxentan

Pfizer has suffered a blow to its drug development programme with the withdrawal of pulmonary arterial hypertension (PAH) brand Thelin …
News

Sanofi extends Genzyme share deal deadline

December 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions

Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
News

Amgen and Actelion meet to “talk takeover”

December 13, 2010 Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover

Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …
News

Novartis pulls Zometa submission after breast cancer failure

December 13, 2010 Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic

Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …
News

China to ‘overtake US in innovation by 2020’

December 13, 2010 Research and Development, Sales and Marketing AstraZeneca, China, India, innovation

China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …
News

Bristol-Myers Squibb appoints new UK general manager

December 13, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Amadou Diarra, BMS, Bristol-Myers Squibb, appointment, recruitment, sales and marketing

Bristol-Myers Squibb has appointed Amadou Diarra as general manager of its UK company, where he will be in charge of …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026